Read More Pharma Industry News Why Cipla’s Goa facility VAI status matters more than a routine USFDA inspection update Cipla has regulatory breathing room, but launches still matter. The Goa VAI status may decide how investors price its US growth story. Read more. byPallavi MadhirajuJune 11, 2026